§ Mr. Paul MarsdenTo ask the Secretary of State for Health what assessment he has made of the risks of taking oral corticosteroids for osteoporosis; and if he will make a statement. [96660]
§ Ms StuartIt is known that prolonged use of corticosteroids is an important risk factor in the development of osteoporosis.
The Royal College of Physicians' evidence based "Clinical guidelines for prevention and treatment of osteoporosis" highlight this fact, as does the quick reference primary care guide issued by the Department. These documents recommend preventive strategies to help doctors with patients who present with this, and a range of other known risk factors.
In addition the National Osteoporosis Society have also published guidance on "The prevention and management of corticosteroid induced osteoporosis". This is also a useful resource for doctors and members of the public alike.
Description Total Quantity 1998–99 (Thousand) Sales 1998–99 (£000) Total Quantity 1997–98 (Thousand) Sales 1997–98 (£000) Disposable nappies 11,909 1,638 11,370 1,615 Incontinence pad, all in one 20,119 7,160 20,691 7,961 Incontinence pad, rectangular 32,816 2,405 40,151 2,835 Incontinence pad, shaped 44,791 9,204 43,636 9,515 Incontinence pad, underpad 33,717 4,181 32,457 3,795 Incontinence pants 5,311 2,303 5,023 2,099 Incontinence pads, reusable 44 241 38 219 Incontinence foam wash 103 362 60 240 Total 148,810 27,494 153,426 28,279 Notes:
NHS Supplies only collect information by the financial year. The last two full years are shown.
All cost information includes Value Added Tax.